Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.54 |
| ▸ | ABAT | P80404 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.54 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.51 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | XDH | P47989 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30924863 | 1.00 | TSHR (0.61) | TSHRBLMNPSR1CYP3A4NFKB1 | |
| SCHEMBL8076108 | 0.91 | TSHR (0.52) | TSHRBLMNPSR1CYP3A4NFKB1 | |
| SCHEMBL12918949 | 0.83 | TSHR (0.58) | TSHRBLMNPSR1CYP3A4NFKB1 | |
| SCHEMBL85711 | 0.83 | TSHR (0.58) | TSHRBLMNPSR1CYP3A4NFKB1 | |
| SCHEMBL11187053 | 0.83 | TSHR (0.57) | TSHRBLMNPSR1CYP3A4NFKB1 | |
| SCHEMBL1360247 | 0.83 | TRPA1 (0.59) | TSHRBLMNPSR1CYP3A4NFKB1 | |
| SCHEMBL16212030 | 0.81 | TSHR (0.55) | TSHRBLMNPSR1CYP3A4NFKB1 | |
| SCHEMBL3988408 | 0.81 | ALDH1A1 (0.47) | TSHRBLMNPSR1CYP3A4NFKB1 | |
| SCHEMBL15270084 | 0.80 | PKM (0.46) | TSHRBLMNPSR1CYP3A4HPGD | |
| SCHEMBL5791212 | 0.80 | TSHR (0.55) | TSHRBLMNPSR1CYP3A4NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114965727-A | Application of biomarker in preparation of product for diagnosing, assisting in diagnosing or predicting polycystic ovary syndrome | 北京三元食品股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| WO-2013173332-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | Vertichem Corporation (CA) | 2013-11-21 | — | — | WO | claimed |
| WO-2013134756-A1 | A METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | Vertichem Corporation (CA) | 2013-09-12 | — | — | WO | claimed |
| US-6284750-B1 | DRUG, COSMETICS STEROID | ESTEE LAUDER INC. | 2001-09-04 | — | — | US | claimed |
| EP-0876391-B1 | NOVEL STEROID ESTERS USEFUL AGAINST SKIN DISORDERS | ESTEE LAUDER INC (US) | 2000-08-16 | — | — | EP | claimed |
| US-6025347-A | Steroid esters useful against skin disorders | ESTEE LAUDER INC. (US) | 2000-02-15 | — | — | US | claimed |
| US-5948418-A | MERCAPTANS | ESTEE LAUDER, INC. (US) | 1999-09-07 | — | — | US | claimed |
| US-5683705-A | Sulfur-based amides and bis-amides useful against skin disorders | ESTEE LAUDER, INC. (US) | 1997-11-04 | — | — | US | claimed |
| EP-4181781-B1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIV KINDERSPITAL BEIDER BASEL (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-4627069-A1 | FOOD AND PHARMACEUTICAL COMPOSITION FOR DETOXIFYING ENDOGENOUS ALDEHYDES | Picoentech Co., Ltd. (KR) | 2025-10-08 | — | — | EP | disclosed |
| US-20250044306-A1 | Methods for Determining Opioid Responsiveness in the Treatment of Pain | EAST CAROLINA UNIVERSITY | 2025-02-06 | — | — | US | disclosed |
| US-20240182915-A1 | FOOD AND PHARMACEUTICAL COMPOSITION FOR DETOXIFYING ENDOGENOUS ALDEHYDES | PICOENTECH Co., LTD. (KR) | 2024-06-06 | — | — | US | disclosed |
| WO-2024117698-A1 | FOOD AND PHARMACEUTICAL COMPOSITION FOR DETOXIFYING ENDOGENOUS ALDEHYDES | PICOENTECH Co., LTD. (KR) | 2024-06-06 | — | — | WO | disclosed |
| US-20240108597-A1 | GALLOYLATED PROCYANIDINS FOR INCREASING INTRACELLULAR NITRIC OXIDE PRODUCTION | UNIVERSITY OF SOUTH FLORIDA (US) | 2024-04-04 | — | — | US | disclosed |
| US-6284750-B1 | DRUG, COSMETICS STEROID | ESTEE LAUDER INC. | 2001-09-04 | — | — | US | disclosed |
| EP-0876391-B1 | NOVEL STEROID ESTERS USEFUL AGAINST SKIN DISORDERS | ESTEE LAUDER INC (US) | 2000-08-16 | — | — | EP | disclosed |
| US-6025347-A | Steroid esters useful against skin disorders | ESTEE LAUDER INC. (US) | 2000-02-15 | — | — | US | disclosed |
| US-5948418-A | MERCAPTANS | ESTEE LAUDER, INC. (US) | 1999-09-07 | — | — | US | disclosed |
| US-5736537-A | Dehydroep:androsterone sailcylate useful against skin atrophy | ESTEE LAUDER, INC. (US) | 1998-04-07 | — | — | US | disclosed |
| US-5683705-A | Sulfur-based amides and bis-amides useful against skin disorders | ESTEE LAUDER, INC. (US) | 1997-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108597-A1 | GALLOYLATED PROCYANIDINS FOR INCREASING INTRACELLULAR NITRIC OXIDE PRODUCTION | NOS1, NOS2, TNNC1 | TSHR 4721/4885BLM 3555/4885NPSR1 3480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.